OPEN END TURBO LONG - ICON Stock

Certificat

DE000MG2HEP8

Market Closed - Börse Stuttgart 14:47:58 2024-05-31 EDT
0.43 EUR -.--% Intraday chart for OPEN END TURBO LONG - ICON
1 month+82.98%
Date Price Change
24-05-31 0.43 -.--%
24-05-30 0.43 +38.71%
24-05-29 0.31 -24.39%
24-05-28 0.41 -.--%
24-05-27 0.41 -4.65%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 02:47 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ICON PUBLIC LIMITED COMPANY
Issuer Morgan Stanley
WKN MG2HEP
ISINDE000MG2HEP8
Date issued 2024-04-17
Strike 278.3 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.43
Lowest since issue 0.119

Company Profile

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Sector
-
More about the company

Ratings for ICON Public Limited Company

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: ICON Public Limited Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
324.8 USD
Average target price
363.1 USD
Spread / Average Target
+11.80%
Consensus